Akebia Therapeutics, Inc.
Customers
4
2 active
Suppliers
0
None disclosed
Largest customer
30%
FMS · FY to 2025-12-31
Named-customer revenue
$129.9M
2 customers · FY to 2025-12-31
Latest period
Dec 31, 2025
10-K filed 2026-02-26
Customers 4
Companies AKBA discloses as major customers, as a share of AKBA revenue. 2 active, 2 lapsed.
| Company | % of AKBA revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| FMS Fresenius Medical Care AG |
30% | $70.9M | FY 2025-12-31 | −18.0pp | Active | 10-K 2026-02-26 |
Fresenius Medical Care Rx 30 % 48 % 40 % | ||||||
| DVA DAVITA INC. |
25% | $59.0M | FY 2025-12-31 | Active | 10-K 2026-02-26 | |
DaVita, Inc. 25 % * * DaVita, Inc. 29 % 16 % | ||||||
| COR Distributor Cencora, Inc. |
19% | $30.4M | FY 2024-12-31 | −2.0pp | Lapsed Last seen 2024-12-31 |
10-K 2026-02-26 |
Cencora, Inc. * 19 % 21 % | ||||||
| CAH Distributor CARDINAL HEALTH INC |
10% | $19.5M | FY 2023-12-31 | Lapsed Last seen 2023-12-31 |
10-K 2026-02-26 | |
Cardinal Health, Inc. * * 10 % | ||||||
Alerts are coming
Get an email when AKBA's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.